Publications by authors named "Julio Osende"

Claim this Profile
L
Local Intracoronary Fibrinolysis with Distal Occlusion: A Series of Cases Using Marinade Technique.
Leire Unzué, Eulogio García, Miguel Rodríguez Del Río, Julio Osende, Rodrigo Teijeiro-Mestre

Cardiovasc Revasc Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Intracoronary Fibrinolysis in Acute Myocardial Infarction of Ectatic Coronary Arteries in the Post-Abciximab Era.
Leire Unzue, Eulogio Garcia, Rodrigo Teijeiro, Carmen Ginestal, Beatriz Fuertes, Julio Osende

Cardiovasc Revasc Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reticulon-4B/Nogo-B acts as a molecular linker between microtubules and actin cytoskeleton in vascular smooth muscle cells.
Juan A Rodríguez-Feo, Julio Gallego-Delgado, Marta Puerto, Francisco Wandosell, Julio Osende

Biochim Biophys Acta· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoproteomics in cardiac hypertrophy and atherosclerosis.
Alberto Lazaro, Gloria Alvarez-Llamas, Julio Gallego-Delgado, Fernando de la Cuesta, Julio Osende

Cardiovasc Hematol Disord Drug Targets· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies.
Julio Gallego-Delgado, Susan B Connolly, Alberto Lázaro, Denise Sadlier, Niamh E Kieran, Julio Osende

Hypertens Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual cause of cardiomegaly.
Esther Pérez David, Julio Osende, Francisco Fernández-Avilés

Eur Heart J· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy.
Julio Gallego-Delgado, Alberto Lazaro, Dulcenombre Gomez-Garre, Julio I Osende, Maria L Gonzalez-Rubio

J Nephrol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney.
Vanesa Esteban, Julio Gallego-Delgado, Alberto Lazaro, Julio Osende, Sergio Mezzano

J Nephrol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.
M Urooj Zafar, Michael E Farkouh, Julio Osende, Daichi Shimbo, Stella Palencia

Thromb Haemost· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of antihypertensive drugs in the heart of animal models: a proteomic approach.
Alberto Lázaro, Julio Gállego-Delgado, Julio I Osende, Jesús Egido, Fernando Vivanco

Methods Mol Biol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI.
Roberto Corti, Julio Osende, Randolph Hutter, Juan F Viles-Gonzalez, Urooj Zafar

Atherosclerosis· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies.
Julio Gallego-Delgado, Alberto Lazaro, Julio I Osende, Vanesa Esteban, Maria G Barderas

J Am Soc Nephrol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy.
Julio Gallego-Delgado, Alberto Lazaro, Julio I Osende, Maria G Barderas, Maria C Duran

J Proteome Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term blood pressure control prevents oxidative renal injury.
Alberto Lazaro, Julio Gallego-Delgado, Pilar Justo, Vanesa Esteban, Julio Osende

Antioxid Redox Signal· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic approach in the search of new cardiovascular biomarkers.
Julio Gallego-Delgado, Alberto Lazaro, Julio I Osende, Maria G Barderas, Luis M Blanco-Colio

Kidney Int Suppl· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins in hypertensive patients: potential explanations for the ASCOT-LLA study results.
Luis Miguel Blanco-Colio, Julio I Osende, Jose Luis Martín-Ventura, José Tuñón, Jesús Egido

Drugs· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study.
Julio I Osende, Marta Ruiz-Ortega, Luis Miguel Blanco-Colio, Jesus Egido

Nephrol Dial Transplant· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
Roberto Corti, Julio I Osende, John T Fallon, Valentin Fuster, Gabor Mizsei

J Am Coll Cardiol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Acute myocardial dysfunction after nasal infiltration with cocaine].
Tomás Datino, Manuel Martínez-Sellés, Juan Quiles, Miriam Suárez, Fernando Sarnago Cebada, Julio I Osende

Rev Esp Cardiol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.
Antonia Sambola, Julio Osende, James Hathcock, Michael Degen, Yale Nemerson

Circulation· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin.
Daichi Shimbo, Julio Osende, Julie Chen, Jonathan Robbins, Yoshimasa Shimoto

Thromb Haemost· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study.
Eli I Lev, Jonathan D Marmur, Milan Zdravkovic, Julio I Osende, Jonathan Robbins

Arterioscler Thromb Vasc Biol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging.
Luis J J Borreguero, Roberto Corti, Rafael F de Soria, Julio I Osende, Valentin Fuster

Circulation· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo noninvasive detection and age definition of arterial thrombus by MRI.
Roberto Corti, Julio I Osende, Zahi A Fayad, John T Fallon, Valentin Fuster

J Am Coll Cardiol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes.
Daichi Shimbo, Josiah Child, Karina Davidson, Eliza Geer, Julio I Osende

Am J Cardiol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis